POT1 and B-cell chronic lymphocytic leukemia: Currently, three more mutations (p.Y36C, p.Q376R, p.Q358S) in the POT1 gene have been identified from CLL patients, predicted to disrupt the interaction of POT1 with TPP1 and telomere overhang which consequently contributed to the CLL pathogenesis [44].